Archive · 4 Oct 2025
Rajasthan Drug Controller Accused of Tampering with Standards
In Rajasthan, a drug controller is accused of changing the rules to make it easier for companies to sell cough syrup, like Kayson Pharma, even if the drugs aren't perfect.
He altered the definition of "fake drugs", making it acceptable if some ingredients are missing.
This could have let lower-quality medicines pass as safe.
A report says that the controller's actions may have been to help several drug companies.
Distribution of Kayson Pharma's drugs has been stopped, and an investigation is underway.
Previously 42 samples of Kayson's medicine were found to be substandard.
Drug Controller Rajaram Sharma is accused of manipulating drug quality standards.
Sharma allegedly changed the definition of a 'fake drug' to benefit pharma companies.
The altered definition may have allowed substandard drugs to be approved.
The Rajasthan government suspended Rajaram Sharma and stopped distribution of Kayson Pharma's drugs.
RMSCL tested 10,119 samples of Kayson Pharma’s medicines since 2012, and 42 were found to be substandard.
- Who
- Rajaram Sharma, Kayson Pharma
- What
- Alleged manipulation of drug quality standards and documents related to fake drugs
- When
- September 2023
- Where
- Rajasthan, India
- Why
- To potentially benefit pharmaceutical companies by lowering medicine quality standards.
- Drug
- Cough syrup
- Manufacturer
- Kayson Pharma
- Location
- Rajasthan, India
- Suspension
- Drug Controller Rajaram Sharma
- Drug Act
- Drugs and Cosmetics Act, 1940
Sources
Firm Behind Cough Syrup Linked To Child Deaths Under Scanner In Rajasthan
Congress’ Surjewala accuses BJP govt in Rajasthan of colluding with blacklisted pharma cos